Cytogenetic study in peripheral blood lymphocytes from asthmatic patients receiving continued therapy with theophylline

Mutat Res. 1992 Oct;280(4):271-7. doi: 10.1016/0165-1218(92)90057-7.

Abstract

Possible cytogenetic effects of theophylline have been investigated in asthmatic patients undergoing continuous therapy with this drug. Sister-chromatid exchanges (SCE), chromosome aberrations (CA) and proliferating rate indices (PRI) were evaluated in cultured peripheral blood lymphocytes from patients receiving theophylline alone, theophylline plus inhaled beta 2 adrenergic drugs or theophylline in combination with beta 2 adrenergic agents and corticoids. Two samples from each individual were obtained in order to perform a prospective study: before the theophylline medication (sample A) and at a time after the beginning of treatment (sample B). After treatment (66.3 +/- 37.8 days), an increase in SCE was observed without modifications either in PRI or in CA. Patients receiving beta 2 adrenergics or beta 2 adrenergics plus glucocorticoids before and during theophylline treatment, did not respond differently than those on theophylline alone.

MeSH terms

  • Adolescent
  • Adult
  • Animals
  • Asthma / blood*
  • Asthma / drug therapy
  • Cell Division / drug effects
  • Cells, Cultured
  • Chromosome Aberrations
  • Drug Therapy, Combination
  • Female
  • Glucocorticoids / therapeutic use
  • Humans
  • Lymphocytes / drug effects*
  • Lymphocytes / pathology
  • Male
  • Middle Aged
  • Mutagens / toxicity*
  • Rats
  • Sister Chromatid Exchange / drug effects
  • Theophylline / adverse effects*
  • Theophylline / therapeutic use

Substances

  • Glucocorticoids
  • Mutagens
  • Theophylline